Health Care Equipment

Varex Imaging

Varex Imaging released FY2026 Q2 earnings on May 7 After-Market EST, actual revenue USD 216 M (forecast USD 216.92 M), actual EPS USD -0.1928 (forecast USD 0.14)

Varex Imaging released FY2026 Semi-Annual Earnings on May 7 After-Market (EST), actual revenue USD 425.6 M, actual EPS USD -0.14

Varex Imaging to Release FY2026 Q2 Earnings on May 7 After-Market EST, Forecast Revenue USD 216.92 M, EPS USD 0.14

Varex Imaging released FY2026 Q1 earnings on February 10 After-Market EST, actual revenue USD 209.6 M (forecast USD 207.8 M), actual EPS USD 0.05 (forecast USD 0.084)

Varex Imaging to release FY2026 Q1 earnings on February 10 After-Market EST, forecast revenue USD 207.83 M, EPS USD 0.0975

Varex Imaging released FY2025 Q4 earnings on November 18 After-Market EST, actual revenue USD 228.9 M (forecast USD 219.26 M), actual EPS USD 0.2923 (forecast USD -2.07)

Varex Imaging released FY2025 Annual Earnings on November 18 After-Market EST, actual revenue USD 844.6 M (forecast USD 834.96 M), actual EPS USD -1.7 (forecast USD -1.9925)

Varex Imaging to Release FY2025 Q4 Earnings on November 18 After-Market (EST), Forecast Revenue USD 219.26 M, EPS USD -2.07

Taylor Analyzes Healthcare Stocks and Provides Recommendations

Varex Imaging released FY2025 9 Months Earnings on August 7 After-Market EST, Actual Revenue: USD 615.7 M, Actual EPS: USD -1.9939

Varex Imaging released FY2025 Q3 earnings on August 7 After-Market (EST), actual revenue USD 203 M (forecast USD 190.32 M), actual EPS USD -2.15 (forecast USD -0.1175)

Varex Imaging to release FY2025 Q3 earnings on August 7 After-Market EST, forecast revenue USD 190.32 M, EPS USD -0.1175

Varex Imaging Secures $17 Million Order

Jay K. Kunkel Reports Disposal of Varex Imaging Corporation Common Stock

S&P Downgrades Varex Imaging Corporation Credit Rating

B. Riley Maintains Varex Imaging Strong Buy Rating

Varex Imaging Reports Q2 2025 Revenue Growth

Varex Imaging released FY2025 Q2 earnings on May 8 After-Market EST, actual revenue USD 212.9 M (forecast USD 206.76 M), actual EPS USD 0.166 (forecast USD 0.06)

Varex Imaging released FY2025 Semi-Annual earnings on May 8 After-Market (EST), actual revenue USD 412.7 M, actual EPS USD 0.16

Varex Imaging Reports 3% Revenue Growth in Second Fiscal Quarter

HCW Biologics

P3 Health Partners

Murano Global BV

Auddia

Super League Enterprise

Trio-Tech Int

Ernexa Therapeutics

Robostrategy

Jiade

VREX

Oppenheimer analyst Suraj Kalia has maintained a Buy rating on Varex Imaging (VREX) with a price target of $18.00. Kalia, who focuses on the Healthcare sector, has an average return of 6.5% and a 49.49% success rate on his stock recommendations. The overall analyst consensus for Varex Imaging is a Moderate Buy, also with an average price target of $18.00.

Tip Ranks

Oppenheimer

Abbott Laboratories

Artivion

Insulet

Varex Imaging (VREX) Receives a Buy from Oppenheimer

LTRX

Lantronix shares are trading lower after the company reported worse-than-expected Q3 sales results.

benzinga_article

Lantronix

Earnings Watch

Varex Imaging | 10-Q: FY2026 Q2 Revenue Misses Estimate at USD 216 M

Varex Imaging | 8-K: FY2026 Q2 Revenue Misses Estimate at USD 216 M

Universal Beteiligungs und Servicegesellschaft mbH acquired a $1.25 million stake in Varex Imaging (NASDAQ:VREX) during Q4, purchasing 107,080 shares. Other institutional investors also increased their positions in VREX. The stock opened at $11.61, with a market cap of $486.46 million. Varex Imaging reported a Q1 EPS of $0.19, exceeding estimates, and set Q2 2026 guidance at 0.150-0.250 EPS. Analysts have mixed ratings on the stock, with a consensus rating of "Moderate Buy" and a price target of $16.17.

Market Beat

Universal Beteiligungs und Servicegesellschaft mbH Takes $1.25 Million Position in Varex Imaging $VREX

Varex Imaging (NASDAQ:VREX) is set to release its Q2 2026 earnings on May 7, with analysts predicting earnings of $0.22 per share and revenue of $216.9 million. The company has provided guidance of $0.150-0.250 EPS. Varex's last earnings report showed $0.19 EPS, exceeding estimates. The stock opened at $11.03, with a market cap of $462.16 million. Recent insider trading saw Director Jay K. Kunkel sell shares, and institutional investors have adjusted their stakes. Analyst ratings vary, with a consensus rating of "Moderate Buy" and a price target of $16.17.

Franklin Resources

Manulife Financial

MANULIFE-S

Deutsche Bank AG

Comerica

BNP Paribas

Jefferies Financial

Deutsche Bank AG Subscription Rights

Deutsche Postbank AG

COMERICA INC 6.875 % DEP PFD SER B

B Riley Financial Pref Share RILYL 7.375 Perp 09/04/25 B

B Riley Financial Pref Share RILYG 7.25 12/21/27

B Riley Financial Pref Share RILYN 6.5 09/30/2026

B Riley Financial Pref Share RILYK 5.5 03/31/26

B Riley Financial Pref Share RILYP 6.875 Perp 10/07/24

B Riley Financial Pref Share RILYZ 5.25 08/31/28

B Riley Financial Pref Share RILYT 6.0 01/31/28

Varex Imaging (VREX) Projected to Post Quarterly Earnings on Thursday

Varex Schedules Second Quarter Fiscal Year 2026 Earnings Release and Conference Call | VREX Stock News

StockTitan

Varex Schedules Second Quarter Fiscal Year 2026 Earnings Release and Conference Call | VREX Stock News

Varex Imaging(VREX.US)

Varex Imaging (VREX) Receives a Buy from Oppenheimer

Lantronix shares are trading lower after the company reported worse-than-expected Q3 sales results.

Varex Imaging | 10-Q: FY2026 Q2 Revenue Misses Estimate at USD 216 M

Varex Imaging | 8-K: FY2026 Q2 Revenue Misses Estimate at USD 216 M

Universal Beteiligungs und Servicegesellschaft mbH Takes $1.25 Million Position in Varex Imaging $VREX

Varex Imaging (VREX) Projected to Post Quarterly Earnings on Thursday

Varex Schedules Second Quarter Fiscal Year 2026 Earnings Release and Conference Call | VREX Stock News